 | Autolus Therapeutics plc | |||
| NMS : AUTL || Location: United Kingdom | ||||
$4.14-0.07 (-1.78%) |
3.11 M | 3.96 - 4.29 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 4.069 M |
| March 28, 2024 | 4.168 M |
| March 15, 2024 | 3.152 M |
| Feb. 29, 2024 | 2.769 M |
| Feb. 15, 2024 | 3.102 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.26 | -0.45 | -74.69% |
| 09/30/2023 | -0.26 | -0.26 | -1.96% |
| 06/30/2023 | -0.23 | -0.26 | -13.64% |
| 03/31/2023 | -0.27 | -0.23 | 15.32% |
| 12/31/2022 | -0.27 | -0.23 | 16.09% |
AUTL Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 265.926M | Shares Float | 91.175M |
| Short Float | 4.069M | Market Cap | 1119.55M |
| Institution ownership | 53.55% | Insider ownership | 18.037% |
| Earnings Date | 05/14/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -1.20 | Forward EPS | -0.59 |